Rational choice of antibacterial drug for the treatment of ent organs in outpatient practice
https://doi.org/10.21518/2079-701X-2018-20-8-12
Abstract
The article examines the choice of a group of antibacterial drugs for the treatment of ENT organs with uncomplicated infections in the practice of the otorhinolaryngologist. Described the principles of antibacterial therapy, resistance of the main pathogens of infections of ENT organs (Streptococcus pneumonia, Streptococcus pyogenes, Haemophilus influenza, Moraxella catarrhalis) to antibiotics of different groups: penicillins, cephalosporins of different generations, macrolides, respiratory fluoroquinolones. It is told about the patient’s compliance to the prescribed treatment, which has a great influence not only on the effectiveness of treatment, but also on the increase of antibiotic resistance in general. A group of cephalosporins of the third generation for oral administration (Cefixime) has some competitive advantages over other groups antibiotics: better adherence like as macrolides and high susceptibility of a wide range of bacteria, like as penicillins and fluoroquinolones.
About the Authors
S. A. Eremin
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
Russian Federation
S. V. Ryazantsev
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
Russian Federation
O. I. Konoplev
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Chow AW, Benninger MS, Brook I et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis, 2012, 54(8): 72-112.
2. Ryazantsev SV, Khamgushkeeva NN, Eremin SA. Antibacterial therapy of acute rhinosinusitis by cefditoren. Meditsinsky Sovet, 2017, 8: 50-52.
3. Eremina NV, Karlov SN, Eremin SA, Goloviznina KS, Nizhegorodtseva IA. Evaluation of epidemiology and microbiological characteristics of purulent otitis in adults and children in the Samara region. Rossiyskaya Otorinolaringologia, 2008, Appendix 2: 240-24
4. Stevanovic T., Komazec Z., Lemajic-Komazec S., Jovic R. Acute otitis media: to follow-up or treat? Int J Pediatr Otorhinolaryngol, 2010 Aug, 74(8): 930-3. doi: 10.1016/j.ijporl.2010.05.017. Epub 2010 Jun 17.
5. Zaplatnikov AL, Girina AA, Lepiseva IV. Algorithms for initial etiotropic therapy for bacterial infections of the upper respiratory tract in children. Meditsinsky Sovet, 2016, 1: 44-49.
6. Strategy and objectives of the rational use of antibiotics in outpatient practice: Eurasian clinical guidelines. Under the editorship of Yakovleva SV, Rafalsky VV, Sidorenko SV, Spichak TV. Moscow. Pre100Print, 2016. 144 p.
7. Hadley JA, Pfaller MA. Oral beta-lactams in the treatment of acute bacterial rhinosinusitis. Diagn Microbiol Infect Dis, 2007, 57(3): 47-54.
8. Jacobs M.R., Bajaksouzian S., Zilles A., Lin G., Pankuch G.A., Appelbaum P.C. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Antimicrob Agents Chemother, 1999 Aug, 43(8): 1901-8.
9. Mayanskiy N, Alyabieva N, Ponomarenko O, Lazareva A, Katosova L, Ivanenko A, et al. Serotypes and antibiotic resistance of noninvasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Int J Infect Dis, 2014, 20: 58-62.
10. Kalinogorskaya OS, Belanov SS, Volkova MO, Gostev VV, Sidorenko SV. Antibiotic resistance and serotyping of Streptococcus pneumoniae isolated from children in St. Petersburg, 2010– 2013. Antibiotiki i Khimioterapia, 2015, 60: 10-18.
11. Nagamune H. Streptococcal cytolysins. Seikagaku, 1997, 69: 343–348.
12. Savinova TA, Sidorenko SV, Budanov SV, Grudinina SA: Dynamics of spread of beta-lactam antibiotics resistance among Streptococcus pneumoniae and its clinical significance. Antibiotiki i Khimioterapia, 2010, 55: 12–20.
13. Kozlov RS, Dekhnich AV. Handbook of antimicrobial therapy. Smolensk: Smolensk Printing Factory, 2010. 415 p.
14. Ferrer P еt al. Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin. Clavulanate-induced Acute Liver Injury. Basic Clin Pharmacol Toxicol, 2016, 119(1): 3-9.
15. Scaglione F., Demartini G., Dugnani S., Arcidiacono M.M., Pintucci J.P., Fraschini F.. Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. Br J Clin Pharmacol, 1999 Mar, 47(3): 267-71.
16. Tristram S., Jacobs M.R., Appelbaum P.C. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev, 2007 Apr, 20(2): 368-89.
17. Llor C, Hernández S, Bayona C, Moragas A, Sierra N, Hernández M, et al. A study of adherence to antibiotic treatment in ambulatory respiratory infections. Int J Infect Dis, 2013 Mar, 17(3): e168-72. doi: 10.1016/j.ijid.2012.09.012. Epub 2012 Oct 29.
18. Pechere J.C., Hughes D., Kardas P., Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents, 2007, 29: 245-53.
19. Yamamoto Y, Kadota J, Watanabe A, Yamanaka N, Tateda K, Mikamo H, et al. Compliance with oral antibiotic regimens and associated factors in Japan: compliance survey of multiple oral antibiotics (COSMOS). Scand J Infect Dis, 2012 Feb, 44(2): 93-9. doi: 10.3109/00365548.2011.619998. Epub 2011 Oct 22.
20. Roche G. Cefixime, the first oral third-generation cephalosporin. Presse Med, 1989 Oct 11, 18(32): 1541-4.
21. Artyushkin SA, Ryazantsev SV, Eremina NV, Eremin SA. Modern phytosecretolytics in the treatment of acute rhinosinusitis. Meditsinsky Sovet, 2018, 8: 98-102.
Review
For citations:
Eremin SA, Ryazantsev SV, Konoplev OI. Rational choice of antibacterial drug for the treatment of ent organs in outpatient practice. Meditsinskiy sovet = Medical Council. 2018;(20):8-12. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-8-12
Views:
901
Email this article 